Literature DB >> 12139441

The structure, regulation, and function of human matrix metalloproteinase-13.

Matthew F Leeman1, Stephanie Curran, Graeme I Murray.   

Abstract

Matrix metalloproteinase-13 (MMP-13) is a proteolytic enzyme that belongs to a large family of extracellular matrix-degrading endopeptidases that are characterized by a zinc-binding motif at their catalytic sites. MMP-13 has a key role in the MMP activation cascade and appears to be critical in bone metabolism and homeostasis. It also has an important role in tumor invasion and metastasis. This commentary provides a detailed overview of the regulatory mechanisms, structure, and function of human MMP-13 and highlights the key factors involved in the biology of this important molecule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139441     DOI: 10.1080/10409230290771483

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  70 in total

1.  IL-6 increases MMP-13 expression and motility in human chondrosarcoma cells.

Authors:  Chih-Hsin Tang; Cheng-Fong Chen; Wei-Ming Chen; Yi-Chin Fong
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

Review 2.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

3.  Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.

Authors:  Ryuichiro Nakai; Cleo M Salisbury; Hugh Rosen; Benjamin F Cravatt
Journal:  Bioorg Med Chem       Date:  2008-03-08       Impact factor: 3.641

4.  Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.

Authors:  Naoko Yamakawa; Tokujiro Uchida; Michael A Matthay; Koshi Makita
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-21       Impact factor: 5.464

5.  Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes.

Authors:  Hee-Jeong Im; Carol Pacione; Susan Chubinskaya; Andre J Van Wijnen; Yubo Sun; Richard F Loeser
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

6.  Increased succinate receptor GPR91 involved in the pathogenesis of Mooren's ulcer.

Authors:  Lin Li; Yan-Ling Dong; Ting Liu; Dan Luo; Chao Wei; Wei-Yun Shi
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

7.  YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site.

Authors:  Shaija Samuel; Katherine K Beifuss; Lori R Bernstein
Journal:  Biochim Biophys Acta       Date:  2007-08-01

Review 8.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

9.  The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts.

Authors:  Wenjun Zong; Leslie A Meyn; Pamela A Moalli
Journal:  Biol Reprod       Date:  2008-11-05       Impact factor: 4.285

10.  Timing-dependent actions of NGF required for cell differentiation.

Authors:  Jaehoon Chung; Hiroyuki Kubota; Yu-ichi Ozaki; Shinsuke Uda; Shinya Kuroda
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.